A5005754439- Global Cancer Incidence and Screening
- Nutrition, Genetics, and Disease
- Colorectal Cancer Screening and Detection
- CAR-T cell therapy research
- BRCA gene mutations in cancer
- Lymphoma Diagnosis and Treatment
- Cancer Risks and Factors
- Cutaneous lymphoproliferative disorders research
- AI in cancer detection
- Bladder and Urothelial Cancer Treatments
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Lysosomal Storage Disorders Research
- Toxic Organic Pollutants Impact
- Cardiovascular Health and Risk Factors
- Carbohydrate Chemistry and Synthesis
- Molecular Biology Techniques and Applications
- Heme Oxygenase-1 and Carbon Monoxide
- Carcinogens and Genotoxicity Assessment
- Digital Radiography and Breast Imaging
- Trypanosoma species research and implications
- Health, Environment, Cognitive Aging
- Health Literacy and Information Accessibility
Inserm
2022-2023
Bordeaux Population Health
2022-2023
UniCancer Group
2020-2022
Université de Bordeaux
2022
Institut Bergonié
2021
Institut Pasteur
2009
MRC Epidemiology Unit
1995
Abstract Background The MyPeBS study is an ongoing randomised controlled trial testing whether a risk-stratified breast cancer screening strategy non-inferior, or eventually superior, to standard age-based at reducing incidence of stage 2 more cancers. This large European Commission-funded initiative aims include 85,000 women aged 40 70 years, without prior and not previously identified high risk in six countries (Belgium, France, Italy, Israel, Spain, UK). A specific work package within...
No AccessJournal of UrologyAdult Urology1 Apr 2009Molecular Analyte Profiling the Early Events and Tissue Conditioning Following Intravesical Bacillus Calmette-Guerin Therapy in Patients With Superficial Bladder Canceris accompanied byIncreased Infiltration Tumor Associated Macrophages is Poor Prognosis Carcinoma In Situ After InstillationPrevention Treatment Transitional Cell Carcinomatosis Intraperitoneal Chemotherapy a Rat Model Aurélie Bisiaux, Nicolas Thiounn, Marc-Olivier Timsit, Ahmed...
To identify any differences in hepatic function between workers exposed to carbon tetrachloride and controls, the best variable with which examine effects.In a cross sectional study of occupationally tetrachloride, 135 employees were compared 276 non-exposed controls. The group was taken from three sites north west England control included one these another site located nearby. Demographic alcohol consumption data collected both groups by questionnaire. Each member allotted notional...
In 2009, a worldwide supply constraint of imiglucerase led to treatment modifications or interruptions for patients with Gaucher disease (GD) type 1. France, joint recommendations were issued protect the most vulnerable patients. This observational study evaluated impact on clinical and biological course GD. Retrospective data patients' characteristics, treatment, parameters from 01 June 2009 31 October 2010 collected during single visit. Ninety-nine GD1 patients, aged 7–84 years, included...
Abstract We compared accuracy for breast cancer (BC) risk stratification of a new fully automated system (DenSeeMammo—DSM) density (BD) assessment to non-inferiority threshold based on radiologists’ visual assessment. Pooled analysis was performed 14,267 2D mammograms collected from women aged 48–55 years who underwent BC screening within three studies: RETomo, Florence study and PROCAS. BD expressed through clinical Breast Imaging Reporting Data System (BI-RADS) classification. Women in...
MyPeBS French Screening Coordination Structures (Centres Régionaux de des Dépistages Cancers, aka CRCDC): CRCDC Ile-de-France (all sites), Haut-de-France Auvergne-Rhône-Alpes (Site du Cantal, Haute-Loire, Puy-de-Dôme - Site Rhône, l'Isère, Drôme/Ardèche, l'Ain), Grand Est territorial Meurthe-et-Moselle, Moselle), Nouvelle-Aquitaine la Gironde, Vienne, Charente, Haute-Vienne), Normandie (Antenne EMMA), Provence-Alpes-Côte d'Azur Vaucluse, Antenne Var), Occitanie Haute Garonne, Territorial...
Abstract Background Currently, mammographic-based breast cancer screening (BCS) using age as the single criterion for population selection, apart from rare high-risk indications, is being questioned its imperfect sensitivity (interval cancers) and specificity (false positive recalls), well risk of over-diagnoses. BC scores incorporating personal family history, mammographic density genetic information based on a polygenic score (PRS) give promisingly accurate likelihood woman developing...
Primary cutaneous diffuse large B-cell lymphoma, leg-type (PCDLBCL-LT) is a rare and aggressive malignancy, mostly occurring on the leg of elderly women (Willemze et al., 2019). PCDLBCL-LT harbors an activated B-cell‒like lymphoma (ABC-DLBCL) signature enriched for mutations involving toll-like receptor, NF-κB pathways (Pham-Ledard 2012; Zhou 2018). The high frequency MYD88L265P mutation in combination with those CD79B PIM1 relates these lymphomas to MCD/C5 subset lymphomas, which includes...